Eremid® Genomic Companies receives CAP accreditation

Advertisement: Click here to learn how to Generate Art From Text


publication date: Jan 26, 2024


 | 


creator/supply: Eremid Genomic Companies

Modern genomics CRO’s CAP accreditation provides to CLIA certification, reinforcing dedication to assembly and exceeding high quality requirements for scientific laboratory testing

Eremid® Genomic Companies, LLC (“Eremid”) publicizes its School of American Pathologists (CAP) accreditation, complementing its November 2022 CLIA certification. This landmark demonstrates Eremid’s dedication to assembly and exceeding regulatory requirements, proving its means to supply high quality and precision in scientific genomics. This noteworthy growth cements Eremid as a trusted accomplice for end-to-end scientific genomics help able to delivering top quality check outcomes.

Eremid’s scientific genomics lab affords the newest in genomics applied sciences and automation, supporting the event of cutting-edge molecular diagnostics. CAP accreditation and CLIA certification reinforce and validate Eremid’s company course, with physicians, sufferers, companions, and clients benefiting from the standard assurance inherent in accreditation. With a broad vary of sequencing applied sciences at its disposal, together with short-read sequencing by Illumina, and the newest long-read sequencing methods from PacBio and Oxford Nanopore Applied sciences, Eremid stands able to advance the analysis, growth, validation, and implementation of scientific genomics testing.

“This can be a very good achievement by our workforce,” says Julian Abery, Eremid’s Chief Enterprise Officer. “Attaining each CAP accreditation and CLIA certification is a testomony to Eremid’s dedication to assembly the very best requirements in dealing with and analyzing scientific genomics samples. We’re dedicated to scientific integrity and information high quality in all elements of our work. With CAP accreditation, our clients and companions can relaxation assured of the effectivity of our processes, accuracy of our outcomes, and adherence to the very best laboratory medication requirements.”

Constructed on a basis of pathologist experience, the School of American Pathologists (CAP) companions with laboratories worldwide to raise the standard of laboratory medication with best-in-class options designed to drive operational excellence, obtain diagnostic confidence, and make sure the finest affected person care. CAP inspectors look at laboratory information and high quality management procedures, in addition to employees {qualifications}, gear, services, security program, and total administration. Acknowledged for rigorous and strong requirements, CAP accreditation elevates high quality and mitigates threat, an necessary approach that laboratories can contribute to improved affected person outcomes.

 

 

About Eremid® Genomic Companies, LLC

Eremid® Genomic Companies is a specialty high-complexity CLIA licensed, CAP-accredited genomics contract analysis group. The corporate supplies technical experience in all elements of genomics, delivering top quality science and information via custom-made, collaborative initiatives for each scientific and analysis shoppers working in human well being, diet, and agbiotech. Eremid has invested in world-class scientific employees, and cutting-edge genomic instrumentation and automation to create a singular providing that meets the rising calls for for increased information high quality, reliability, and accuracy in genomics analysis and testing.

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *